You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

LIDOSITE TOPICAL SYSTEM KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Lidosite Topical System Kit, and what generic alternatives are available?

Lidosite Topical System Kit is a drug marketed by Vyteris and is included in one NDA.

The generic ingredient in LIDOSITE TOPICAL SYSTEM KIT is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIDOSITE TOPICAL SYSTEM KIT?
  • What are the global sales for LIDOSITE TOPICAL SYSTEM KIT?
  • What is Average Wholesale Price for LIDOSITE TOPICAL SYSTEM KIT?
Summary for LIDOSITE TOPICAL SYSTEM KIT
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:LIDOSITE TOPICAL SYSTEM KIT at DailyMed
Drug patent expirations by year for LIDOSITE TOPICAL SYSTEM KIT

US Patents and Regulatory Information for LIDOSITE TOPICAL SYSTEM KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LIDOSITE TOPICAL SYSTEM KIT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ⤷  Sign Up ⤷  Sign Up
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ⤷  Sign Up ⤷  Sign Up
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ⤷  Sign Up ⤷  Sign Up
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ⤷  Sign Up ⤷  Sign Up
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LIDOSITE TOPICAL SYSTEM KIT

See the table below for patents covering LIDOSITE TOPICAL SYSTEM KIT around the world.

Country Patent Number Title Estimated Expiration
France 2799656 CIRCUITS POUR AUGMENTER LA FIABILITE D'UN SYSTEME D'IONOPHORESE ⤷  Sign Up
Australia 655859 ⤷  Sign Up
Canada 2084734 SYSTEME D'IONTOPHORESE DONT LES CARACTERISTIQUES REDUISENT L'IRRITATION CUTANEE (IONTOPHORESIS SYSTEM HAVING FEATURES FOR REDUCING SKIN IRRITATION) ⤷  Sign Up
Canada 2364414 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 0074772 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.